Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review.
COVID-19
HSV
Herpes simplex
ICU
Pneumonia
Reactivation
SARS-CoV-2
Journal
Infectious diseases and therapy
ISSN: 2193-8229
Titre abrégé: Infect Dis Ther
Pays: New Zealand
ID NLM: 101634499
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
30
05
2022
accepted:
04
07
2022
pubmed:
2
8
2022
medline:
2
8
2022
entrez:
1
8
2022
Statut:
ppublish
Résumé
Systemic or pulmonary reactivations of herpes simplex virus 1 (HSV-1) have been reported in critically ill patients with COVID-19, posing a dilemma for clinicians in terms of their diagnostic and clinical relevance. Prevalence of HSV-1 reactivation may be as high as > 40% in this population, but with large heterogeneity across studies, likely reflecting the different samples and/or cut-offs for defining reactivation. There is frequently agreement on the clinical significance of HSV-1 reactivation in the presence of severe manifestations clearly attributable to the virus. However, the clinical implications of HSV-1 reactivations in the absence of manifest signs and symptoms remain controversial. Our review aims at providing immunological background and at reviewing clinical findings on HSV-1 reactivations in critically ill patients with COVID-19.
Identifiants
pubmed: 35913679
doi: 10.1007/s40121-022-00674-0
pii: 10.1007/s40121-022-00674-0
pmc: PMC9340740
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1779-1791Informations de copyright
© 2022. The Author(s).
Références
Front Immunol. 2020 Oct 14;11:580237
pubmed: 33154753
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
J Crit Care. 2011 Aug;26(4):432.e1-6
pubmed: 21129912
Biomed Pharmacother. 2020 Dec;132:110859
pubmed: 33120236
Intensive Care Med. 2021 Feb;47(2):180-187
pubmed: 33506379
Physiol Res. 2021 Dec 16;70(S2):S227-S247
pubmed: 34913354
Nutrition. 2013 Jan;29(1):207-12
pubmed: 22951153
J Med Virol. 2004 Jan;72(1):121-5
pubmed: 14635019
Curr Opin Virol. 2011 Dec;1(6):476-86
pubmed: 22323926
Biochimie. 2007 Jun-Jul;89(6-7):878-83
pubmed: 17561326
Ann Rheum Dis. 2016 Oct;75(10):1843-7
pubmed: 27113415
Crit Care. 2020 Aug 28;24(1):530
pubmed: 32859241
Clin Microbiol Infect. 2009 Apr;15(4):358-63
pubmed: 19260875
JAMA Intern Med. 2020 Feb 1;180(2):263-272
pubmed: 31841577
Clin Microbiol Infect. 2020 Nov;26(11):1537-1544
pubmed: 32810610
Rev Med Virol. 2017 Jan;27(1):
pubmed: 27714898
Clin Microbiol Infect. 2022 Apr;28(4):580-587
pubmed: 34454093
Lancet. 2021 May 01;397(10285):1637-1645
pubmed: 33933206
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Nat Rev Immunol. 2020 Jul;20(7):397-398
pubmed: 32457522
Lancet Rheumatol. 2020 Jul;2(7):e428-e436
pubmed: 32835246
PLoS One. 2020 Aug 20;15(8):e0237831
pubmed: 32817707
Multidiscip Respir Med. 2022 Mar 01;17(1):815
pubmed: 35340709
PLoS Pathog. 2021 Apr 16;17(4):e1009448
pubmed: 33861802
Lancet Respir Med. 2020 Dec;8(12):1201-1208
pubmed: 32861276
Microorganisms. 2021 Sep 07;9(9):
pubmed: 34576791
Lancet. 2003 Nov 8;362(9395):1536-41
pubmed: 14615108
Intensive Care Med. 2008 Dec;34(12):2202-9
pubmed: 18679655
Ann Hematol. 2022 Jan;101(1):229-231
pubmed: 33458783
Expert Rev Respir Med. 2022 Apr;16(4):437-446
pubmed: 35341424
J Infect Dis. 2016 Oct 1;214 Suppl 2:S67-74
pubmed: 27625433
Nat Med. 2009 May;15(5):496-7
pubmed: 19424209
Cytokine Growth Factor Rev. 2013 Apr;24(2):91-104
pubmed: 23102645
Endocrinol Diabetes Metab. 2020 Aug 14;4(1):e00176
pubmed: 32904932
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Front Biosci (Landmark Ed). 2021 Sep 30;26(9):405-408
pubmed: 34590454
Ir J Med Sci. 2022 Jun;191(3):1093-1097
pubmed: 34247308
Am J Respir Crit Care Med. 2007 May 1;175(9):935-42
pubmed: 17234903
J Infect. 2019 Feb;78(2):127-133
pubmed: 30267802
Crit Care. 2020 Sep 29;24(1):584
pubmed: 32993740
Infect Dis Now. 2021 Nov;51(8):676-679
pubmed: 34332165
J Virol. 2022 Feb 23;96(4):e0151021
pubmed: 34935440
Cell Rep. 2020 Oct 6;33(1):108234
pubmed: 32979938
PLoS One. 2021 Jul 1;16(7):e0254129
pubmed: 34197543
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
Clin Infect Dis. 2021 Jul 1;73(1):e252-e255
pubmed: 32840571
Adv Exp Med Biol. 2015;872:217-33
pubmed: 26215996
Nat Med. 2022 Jan;28(1):201-211
pubmed: 34782790
Nat Genet. 2003 Mar;33(3):388-91
pubmed: 12590259
Front Immunol. 2021 Sep 20;12:742631
pubmed: 34616404
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Gene Rep. 2021 Dec;25:101417
pubmed: 34778602
Nat Immunol. 2022 Feb;23(2):165-176
pubmed: 35105981
Clin Transl Immunology. 2021 Aug 17;10(8):e1327
pubmed: 34429968
Infect Dis Rep. 2021 Dec 10;13(4):1053-1060
pubmed: 34940406
PLoS Pathog. 2015 Jul 08;11(7):e1005028
pubmed: 26153886
Microorganisms. 2022 Feb 04;10(2):
pubmed: 35208817
Br J Dermatol. 2020 Dec;183(6):1145-1147
pubmed: 32790074
J Clin Med. 2021 Feb 03;10(4):
pubmed: 33546093
Cureus. 2021 Sep 16;13(9):e18022
pubmed: 34667693
J Clin Virol. 2013 Sep;58(1):79-83
pubmed: 23731844
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
PLoS One. 2012;7(12):e51340
pubmed: 23236477
Crit Care. 2021 Dec 6;25(1):417
pubmed: 34872611